Page last updated: 2024-11-03

risperidone and Neurodegenerative Diseases

risperidone has been researched along with Neurodegenerative Diseases in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.

Research Excerpts

ExcerptRelevanceReference
"Risperidone was well tolerated in the elderly and associated with a low risk of movement disorders and anticholinergic effects."2.42Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update. ( DeVane, CL; Mintzer, J, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeVane, CL1
Mintzer, J1

Reviews

1 review available for risperidone and Neurodegenerative Diseases

ArticleYear
Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update.
    Psychopharmacology bulletin, 2003, Volume: 37, Issue:4

    Topics: Aged; Antipsychotic Agents; Humans; Mental Disorders; Neurodegenerative Diseases; Risperidone

2003